Cheryl R. Blanchard, Ph.D., is a distinguished leader in the field of medical technology and currently serves as the President and Chief Executive Officer at Anika Therapeutics, Inc. Dr. Blanchard joined Anika in 2017 and has since been instrumental in steering the company towards significant growth and innovation. With a robust background in biomedical engineering and extensive experience in the medical device industry, she has been pivotal in expanding Anika's product portfolio and enhancing its market presence. Under her leadership, Anika has focused on developing and commercializing innovative solutions for joint preservation, restoration, and regeneration, aiming to improve patient outcomes globally. Prior to her role at Anika, Dr. Blanchard held various leadership positions that honed her skills and expertise. She was the Executive Vice President and Chief Scientific Officer at Zimmer Biomet, where she led the company's research and development efforts, driving advancements in orthopedic solutions. Her career also includes a significant tenure at Smith & Nephew, where she served as Vice President of Research and Development. Dr. Blanchard's academic credentials are equally impressive; she holds a Ph.D. in Biomedical Engineering from Tulane University and has authored numerous publications and patents in her field. Her contributions to the industry have been recognized with several awards, including the prestigious Women in Technology Leadership Award. As CEO of Anika Therapeutics, Dr. Blanchard is committed to fostering a culture of innovation and excellence. She oversees the company's strategic direction, ensuring that Anika remains at the forefront of regenerative medicine and orthopedic solutions. Her leadership has been crucial in navigating the company through the complexities of the global healthcare market, and her vision continues to drive Anika's mission to improve the quality of life for patients worldwide. Dr. Blanchard's dedication to advancing medical technology and her passion for improving patient care make her a transformative figure in the industry.